Transaction · 0000950170-25-014813

Crystal Adam

Crystal Adam, SR, reported a transaction classified as grant at Tango Therapeutics, Inc. involving 53015.000000 shares for an estimated $0.00. Reported holdings after the transaction were 172493.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ASR
TNGXTango Therapeutics, Inc.
Filing timeFeb 06
Trade dateFeb 03, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

TNGX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TNGX since 2025-02-06Filed 574 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0000950170-25-014813
Common Stock
Transaction date
Feb 03, 2025
Filed Feb 06, 2025, 12:34 AM · 3d delay
Shares
53.0k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
172k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year per…

  2. F2

    This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Original filing · 0000950170-25-014813
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TNGX